Alloplant

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Alloplant is an experimental, chemically processed biomaterial used for transplantation. It is made primarily from deceased human flesh; the tissue is subjected to radiating sterilization and is being studied for possible regeneration of tissues of the recipient. The concept has been rejected by the general medical community.

Use in eye transplant[edit]

The primary advocate of alloplants is the Russian surgeon Ernest Muldashev. In 2000, he claimed to have successfully transplanted a human eye onto a blind woman using a harvested cornea and retina combined with an alloplant.

The operation happened after he and his colleagues made a trip to Tibet. According to Muldashev, this voyage gave him an innate and unprecedented understanding of certain worldly ideas and concepts, he claims he witnessed paranormal phenomena involving "time mirrors" in search of forefather "giants".

The claim was widely rejected by the scientific and medical community. Although they avoid the use of the term "quack", doctors interviewed by The Guardian maintain that such transplants are medically impossible and not supported by peer-reviewed medical evidence. Nevertheless, the patient in question claims to have developed the ability to distinguish shapes, colors, and even letters with her transplanted eye.[1] Two ophthalmologists from Nevada published a paper in 2008 concluding that the alloplant method reduced intraocular pressure, one of the main ways of treating glaucoma, and assisted tissue regeneration.[2]

References[edit]